Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

谱系(遗传) 生物 化学 计算生物学 药物发现 生物信息学 遗传学 基因
作者
Loren Lasko,Clarissa G. Jakob,Rohinton Edalji,Wei Qiu,Debra Montgomery,Enrico L. DiGiammarino,T. Matt Hansen,Roberto M. Risi,Robin R. Frey,Vlasios Manaves,Bailin Shaw,Mikkel A. Algire,Paul Hessler,Lloyd T. Lam,Tamar Uziel,Emily J. Faivre,Debra C. Ferguson,Fritz G. Buchanan,Ruth L. Martin,Maricel Torrent
出处
期刊:Nature [Nature Portfolio]
卷期号:550 (7674): 128-132 被引量:843
标识
DOI:10.1038/nature24028
摘要

A potent and selective catalytic inhibitor of p300/CBP histone acetyltransferases suppresses tumour proliferation across multiple cell lineages, illustrating the therapeutic potential of drug-like small molecules that target histone acetyltransferases. The dynamic and reversible acetylation of proteins, catalysed by histone acetyltransferases (HATs) and histone deacetylases (HDACs), is a major epigenetic regulatory mechanism of gene transcription1 and is associated with multiple diseases. Histone deacetylase inhibitors are currently approved to treat certain cancers, but progress on the development of drug-like histone actyltransferase inhibitors has lagged behind2. The histone acetyltransferase paralogues p300 and CREB-binding protein (CBP) are key transcriptional co-activators that are essential for a multitude of cellular processes, and have also been implicated in human pathological conditions (including cancer3). Current inhibitors of the p300 and CBP histone acetyltransferase domains, including natural products4, bi-substrate analogues5 and the widely used small molecule C6466,7, lack potency or selectivity. Here, we describe A-485, a potent, selective and drug-like catalytic inhibitor of p300 and CBP. We present a high resolution (1.95 Å) co-crystal structure of a small molecule bound to the catalytic active site of p300 and demonstrate that A-485 competes with acetyl coenzyme A (acetyl-CoA). A-485 selectively inhibited proliferation in lineage-specific tumour types, including several haematological malignancies and androgen receptor-positive prostate cancer. A-485 inhibited the androgen receptor transcriptional program in both androgen-sensitive and castration-resistant prostate cancer and inhibited tumour growth in a castration-resistant xenograft model. These results demonstrate the feasibility of using small molecule inhibitors to selectively target the catalytic activity of histone acetyltransferases, which may provide effective treatments for transcriptional activator-driven malignancies and diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
丘比特的应助被科研通管家采纳,获得10
刚刚
jr完成签到 ,获得积分10
刚刚
刚刚
1秒前
haibo完成签到,获得积分10
1秒前
顾矜的应助被科研通管家采纳,获得10
1秒前
WenwenBian完成签到,获得积分10
1秒前
慕青的应助被科研通管家采纳,获得10
1秒前
yangliu071998发布了新的文献求助10
1秒前
Hello的应助被科研通管家采纳,获得10
1秒前
研友_VZG7GZ的应助被飞行的子弹采纳,获得10
1秒前
英姑的应助被科研通管家采纳,获得10
1秒前
科研通AI6.2的应助被鹤轸采纳,获得10
1秒前
小马甲的应助被meow采纳,获得10
1秒前
1秒前
共享精神的应助被科研通管家采纳,获得10
1秒前
思源的应助被科研通管家采纳,获得10
1秒前
香蕉觅云的应助被科研通管家采纳,获得30
2秒前
程林翰山发布了新的文献求助10
2秒前
2秒前
Akim的应助被郑一采纳,获得10
2秒前
2秒前
搜集达人的应助被科研通管家采纳,获得10
2秒前
Hello的应助被科研通管家采纳,获得10
2秒前
带着猪逛公园完成签到,获得积分10
2秒前
king完成签到,获得积分20
2秒前
畅快的静蕾完成签到,获得积分10
2秒前
大个的应助被科研通管家采纳,获得10
2秒前
惠惠发布了新的文献求助10
2秒前
bonnie发布了新的文献求助10
2秒前
缥缈听白的应助被科研通管家采纳,获得10
3秒前
Zuouo发布了新的文献求助10
3秒前
领导范儿的应助被科研通管家采纳,获得10
3秒前
3秒前
xiepeijuan的应助被合着采纳,获得10
4秒前
xiyue发布了新的文献求助20
4秒前
4秒前
joker发布了新的文献求助50
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8169459
求助须知:如何正确求助?哪些是违规求助? 9562535
关于积分的说明 21766045
捐赠科研通 7761050
什么是DOI,文献DOI怎么找? 3430397
关于科研通互助平台的介绍 2554220
邀请新用户注册赠送积分活动 2475026